Amneal Pharmaceuticals, Inc. (AMRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:34PM EDT. Market open.
| Previous close | 6.75 |
| Open | 6.75 |
| Bid | 6.66 x 100 |
| Ask | 6.75 x 100 |
| Day's range | 6.68 - 6.81 |
| 52-week range | 2.29 - 7.25 |
| Volume | |
| Avg. volume | 1,557,379 |
| Market cap | 2.07B |
| Beta (5Y monthly) | 1.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.73 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 8.00 |
Business WireAmneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies
BRIDGEWATER, N.J., June 05, 2024--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") today announced the continued expansion of its injectables portfolio with six new injectable product launches during the second quarter of 2024, bringing the Company’s total number of commercial injectable products available for the U.S. institutional market to over 40.
Business WireAmneal to Participate at Upcoming Investor Conference
BRIDGEWATER, N.J., May 22, 2024--Amneal to Participate at Upcoming Investor Conference
Business WireAmneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California
BRIDGEWATER, N.J., May 22, 2024--Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California
© 2024 Yahoo. All rights reserved.